Expertise in
1
conditions

Stephan Eisenmann

Ernst Grube Str. 40, 
Halle, NI, DE 
Expertise in
1
conditions
Ernst Grube Str. 40, 
Halle, NI, DE 

Overview

Stephan Eisenmann practices practicing medicine in Halle, Germany.

Mr. Eisenmann is highly rated in 1 condition, according to our data. His clinical expertise encompasses Emphysema, Chronic Obstructive Pulmonary Disease (COPD), Pneumonia, COVID-19, and Endoscopy.

He is actively involved in clinical research, co-authoring 57 peer reviewed articles and participating in 4 clinical trials.

Gender

Male

Locations

Ernst Grube Str. 40, Halle, NI 06120, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Randomized, Open Label Phase 2/3 Study Comparing Cobolimab + Dostarlimab + Docetaxel To Dostarlimab + Docetaxel To Docetaxel Alone In Participants With Advanced Non-small Cell Lung Cancer Who Have Progressed On Prior Anti-PD-(L)1 Therapy And Chemotherapy (COSTAR Lung)
A Randomized, Open Label Phase 2/3 Study Comparing Cobolimab + Dostarlimab + Docetaxel To Dostarlimab + Docetaxel To Docetaxel Alone In Participants With Advanced Non-small Cell Lung Cancer Who Have Progressed On Prior Anti-PD-(L)1 Therapy And Chemotherapy (COSTAR Lung)
Enrollment Status: Active_not_recruiting
Publish Date: July 01, 2026
Intervention Type: Biological, Drug
Study Drugs: Cobolimab, Dostarlimab, Docetaxel
Study Phase: Phase 2/Phase 3
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Sotatercept When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy in Newly Diagnosed Intermediate- and High-risk PAH Patients
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Sotatercept When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy in Newly Diagnosed Intermediate- and High-risk PAH Patients
Enrollment Status: Terminated
Publish Date: June 08, 2026
Intervention Type: Other, Drug
Study Drug: Sotatercept
Study Phase: Phase 3
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Compare the Efficacy and Safety of Sotatercept Versus Placebo When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy for the Treatment of PAH
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Compare the Efficacy and Safety of Sotatercept Versus Placebo When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy for the Treatment of PAH
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug, Biological
Study Drug: Sotatercept
Study Phase: Phase 3
View 2 Less Clinical Trials

57 Total Publications

Fatal disseminated Rhizomucor pusillus mucormycosis with pulmonary involvement diagnosed by contrast-enhanced ultrasound (CEUS) and transcutaneous biopsy in a patient with acute myeloid leukemia.
Fatal disseminated Rhizomucor pusillus mucormycosis with pulmonary involvement diagnosed by contrast-enhanced ultrasound (CEUS) and transcutaneous biopsy in a patient with acute myeloid leukemia.
Journal: Ultraschall in der Medizin (Stuttgart, Germany : 1980)
Published: May 21, 2026

Frequently Asked Questions about Stephan Eisenmann

Is Stephan Eisenmann a top-rated expert for Emphysema?

MediFind is an objective health platform that identifies experts based on real-world data. Stephan Eisenmann is classified as an Advanced expert for Emphysema, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Stephan Eisenmann participate in research or clinical trials?

Yes. Stephan Eisenmann has published 57 articles and abstracts on conditions like Emphysema. You can view a list of Stephan Eisenmann's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Eisenmann's expertise for a condition
ConditionClose
      View All 24 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile